Characteristics of eosinophilic and non-eosinophilic asthma during treatment with inhaled corticosteroids

Journal of Asthma

Volumn 52, Issue 4, 2015, Pages 417-422

  Furukawa, Toshiki ^a   Sakagami, Takuro ^a   Koya, Toshiyuki ^a   Hasegawa, Takashi ^b   Kawakami, Hidenori ^a   Kimura, Yosuke ^a   Hoshino, Yoshifumi ^a   Sakamoto, Hirotaka ^a   Shima, Kenjiro ^a   Tsukioka, Keisuke ^a   Toyama, Mio ^a   Hayashi, Masachika ^a   Kagamu, Hiroshi ^a   Suzuki, Ei Ichi ^b   Narita, Ichiei ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Eosinophilic asthma; Inhaled cortico steroid; Non eosinophilic asthma; Regulatory T cell; Th17 cell

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; C REACTIVE PROTEIN; CD4 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; PROCATEROL; TRANSCRIPTION FACTOR FOXP3; CORTICOSTEROID;

ADULT; ARTICLE; ASTHMA; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; EOSINOPHIL COUNT; EOSINOPHILIC ASTHMA; FEMALE; FLOW CYTOMETRY; HUMAN; INFLAMMATORY CELL; LEUKOCYTE; MALE; MIDDLE AGED; NEUTROPHIL COUNT; NONEOSINOPHILIC ASTHMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT INFLAMMATION; SPUTUM ANALYSIS; T LYMPHOCYTE; TH17 CELL; TH2 CELL; COMPLICATION; CYTOLOGY; EMERGENCY HEALTH SERVICE; EOSINOPHILIA; FORCED EXPIRATORY VOLUME; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; NEUTROPHIL; SPUTUM; STATISTICS AND NUMERICAL DATA;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ASTHMA; EMERGENCY SERVICE, HOSPITAL; EOSINOPHILIA; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOCYTES; NEUTROPHILS; SPUTUM; T-LYMPHOCYTES;

EID: 84931078478     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2014.975357     Document Type: Article

References (43)

1. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001; 119:1329-1336.
2. Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Noneosinophilic corticosteroid unresponsive asthma. Lancet 1999;353: 2213-2214.
3. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999;160):1532-1539.
4. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002;57:875-879.
5. McGrath KW, Icitovic N, Boushey HA, Lazarus SC, Sutherland ER, Chinchilli VM, Fahy JV. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med 2012;185:612-619.
6. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007;8:345-350.
7. Oboki K, Ohno T, Saito H, Nakae S. Th17 and allergy. Allergol Int 2008;57:121-134.
8. Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev 2008;226:87-102.
9. Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, Dupont LJ, et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 2006;7:135.
10. Al-Ramli W, Prefontaine D, Chouiali F, Martin JG, Olivenstein R, Lemiere C, Hamid Q. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol 2009;123: 1185-1187.
11. Wilson RH, Whitehead GS, Nakano H, Free ME, Kolls JK, Cook DN. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am J Respir Crit Care Med 2009;180:720-730.
12. Alcorn JF, Crowe CR, Kolls JK. TH17 cells in asthma and COPD. Annu Rev Physiol 2010;72:495-516.
13. Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F. Th17 cells: new players in asthma pathogenesis. Allergy 2011;66: 989-998.
14. Barczyk A, Pierzchala W, Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 2003;97:726-733.
15. Kawakami H, Koya T, Kagamu H, Kimura Y, Sakamoto H, Yamabayashi C, Furukawa T, et al. IL-17 eliminates therapeutic effects of oral tolerance in murine airway allergic inflammation. Clin Exp Allergy 2012;42:946-957.
16. Wang W, Shao S, Jiao Z, Guo M, Xu H, Wang S. The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol Int 2012;32:887-893.
17. Eastaff-Leung N, Mabarrack N, Barbour A, Cummins A, Barry S. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol 2010; 30:80-89.
18. Yang J, Chu Y, Yang X, Gao D, Zhu L, Wan L, Li M, et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 2009;60:1472-1483.
19. Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, Yao R, et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008;127:89-97.
20. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113: 59-65.
21. Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006;117:549-556.
22. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, Dolovich J, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;47: 25-29.
23. Spanevello A, Confalonieri M, Sulotto F, Romano F, Balzano G, Migliori GB, Bianchi A, et al. Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med 2000;162:1172-1174.
24. Belda J, Leigh R, Parameswaran K, O'Byrne PM, Sears MR, Hargreave FE. Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med 2000;161:475-478.
25. Haldar P, Pavord ID. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol 2007;119: 1043-14052; quiz 53-54.
26. Synek M, Beasley R, Frew AJ, Goulding D, Holloway L, Lampe FC, Roche WR, et al. Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med 1996; 154:224-230.
27. Sont JK, Han J, van Krieken JM, Evertse CE, Hooijer R, Willems LN, Sterk PJ. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 1996;51: 496-502.
28. Lim S, Jatakanon A, John M, Gilbey T, O'Connor BJ, Chung KF, Barnes PJ. Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma. Am J Respir Crit Care Med 1999;159:22-30.
29. Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000;161:9-16.
30. Tattersfield AE, Knox AJ, Britton JR, Hall IP. Asthma. Lancet 2002;360:1313-1322.
31. Miranda C, Busacker A, Balzar S, Trudeau J, Wenzel SE. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004;113: 101-108.
32. Silkoff PE, Lent AM, Busacker AA, Katial RK, Balzar S, Strand M, Wenzel SE. Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J Allergy Clin Immunol 2005;116:1249-1255.
33. Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 2010;65:384-390.
34. Matsunaga K, Yanagisawa S, Hirano T, Ichikawa T, Koarai A, Akamatsu K, Sugiura H, et al. Associated demographics of persistent exhaled nitric oxide elevation in treated asthmatics. Clin Exp Allergy 2012;42:775-781.
35. Liang SC, Long AJ, Bennett F, Whitters MJ, Karim R, Collins M, Goldman SJ, et al. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol 2007;179:7791-7799.
36. Pelletier M, Maggi L, Micheletti A, Lazzeri E, Tamassia N, Costantini C, Cosmi L, et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010;115:335-343.
37. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006;212:8-27.
38. Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, Skoogh BE, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999;162: 2347-2352.
39. Doe C, Bafadhel M, Siddiqui S, Desai D, Mistry V, Rugman P, McCormick M, et al. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 2010; 138:1140-1147.
40. Provoost S, Maes T, van Durme YM, Gevaert P, Bachert C, Schmidt-Weber CB, Brusselle GG, et al. Decreased FOXP3 protein expression in patients with asthma. Allergy 2009;64:1539-1546.
41. Karagiannidis C, Akdis M, Holopainen P, Woolley NJ, Hense G, Ruckert B, Mantel PY, et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004;114:1425-1433.
42. Martin H, Taube C. Regulatory T cells and regulation of allergic airway disease. Am J Clin Exp Immunol 2012;1:166-178.
43. McGee HS, Edwan JH, Agrawal DK. Flt3-L increases CD4+CD25+ Foxp3+ICOS+ cells in the lungs of cockroach-sensitized and-challenged mice. Am J Respir Cell Mol Biol 2010;42:331-340.